China’s BGI Teams Up With CHOP For Genomics Work In Rare Diseases
This article was originally published in PharmAsia News
Executive Summary
China’s genomics leader, BGI, has furthered its U.S. presence with a collaboration with the Children’s Hospital of Philadelphia focusing on rare disease diagnostics.